Stonebrook Private’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Stonebrook Private's BMY Position: Q2 2026 in Review
Stonebrook Private increased its Bristol-Myers Squibb (BMY) stake by 0.06% in Q2 2026, buying an estimated $345 and bringing the position to 10,555 shares worth $608K. The position accounts for 0.11% of the portfolio, ranked #122.
Stonebrook Private first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.16M in Q1 2024. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Stonebrook Private held 10,555 shares of Bristol-Myers Squibb worth $608K as of Q2 2026.
- Stonebrook Private bought 6 Bristol-Myers Squibb shares in Q2 2026, an estimated $345.
- Bristol-Myers Squibb made up 0.11% of Stonebrook Private's portfolio in Q2 2026, its #122 holding.
- Stonebrook Private first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Stonebrook Private's Bristol-Myers Squibb position peaked at $1.16M in Q1 2024.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.